Search research articles
Contact Us
Filters
Showing results (121-130 of 151) with videos related to
Page
of 16
Sort By:
Blood
|
March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition
Erin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
British Journal of Haematology
|
May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation
Kristie A Blum, Zhongfa Liu, David M Lucas, et al.
British Journal of Haematology
|
June 7, 2018
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials
Jeffrey Jones, Anthony Mato, Steven Coutre, et al.
Blood
|
June 5, 2010
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
Sarah E M Herman, Amber L Gordon, Amy J Wagner, et al.
Blood
|
February 14, 2018
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience
Susan O'Brien, Richard R Furman, Steven Coutre, et al.
American Journal of Hematology
|
April 8, 2026
Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up
Jennifer A Woyach, Relja Popovic, Emily L Rossi, et al.
Nature Reviews. Urology
|
April 26, 2019
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018
Yair Lotan, Trinity J Bivalacqua, Tracy Downs, et al.
Blood
|
December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody
Farrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
Molecular Pain
|
October 27, 2015
MicroRNA circulating in the early aftermath of motor vehicle collision predict persistent pain development and suggest a role for microRNA in sex-specific pain differences
Sarah D Linnstaedt, Margaret G Walker, Joel S Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2023
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions
Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 151) with videos related to
Sort By:
Page
of 16
Blood
|
March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition
Erin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
British Journal of Haematology
|
May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation
Kristie A Blum, Zhongfa Liu, David M Lucas, et al.
British Journal of Haematology
|
June 7, 2018
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials
Jeffrey Jones, Anthony Mato, Steven Coutre, et al.
Blood
|
June 5, 2010
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
Sarah E M Herman, Amber L Gordon, Amy J Wagner, et al.
Blood
|
February 14, 2018
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience
Susan O'Brien, Richard R Furman, Steven Coutre, et al.
American Journal of Hematology
|
April 8, 2026
Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up
Jennifer A Woyach, Relja Popovic, Emily L Rossi, et al.
Nature Reviews. Urology
|
April 26, 2019
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018
Yair Lotan, Trinity J Bivalacqua, Tracy Downs, et al.
Blood
|
December 8, 2009
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody
Farrukh T Awan, Rosa Lapalombella, Rossana Trotta, et al.
Molecular Pain
|
October 27, 2015
MicroRNA circulating in the early aftermath of motor vehicle collision predict persistent pain development and suggest a role for microRNA in sex-specific pain differences
Sarah D Linnstaedt, Margaret G Walker, Joel S Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 29, 2023
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions
Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, et al.
Page
of 16